Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Natural killer cells are capable of killing tumor and virus-infected cells. This killing is mediated primarily via the natural cytotoxicity receptors, including NKp46, NKp44, NKp30, and by the NKG2D receptor. Killer cell Ig-like receptors (KIRs) are mainly involved in inhibiting NK killing (inhibitory KIRs) via interaction with MHC class I molecules. Some KIRs, however, have been found to enhance NK killing when interacting with MHC class I molecules (activating KIRs). We have previously demonstrated that KIR2DS4, an activating KIR, recognizes the HLA-Cw4 protein. The interaction observed was weak and highly restricted to HLA-Cw4 only. These findings prompted us to check whether KIR2DS4 might have additional ligand(s). In this study, we show that KIR2DS4 is able to also interact with a non-class I MHC protein expressed on melanoma cell lines and on a primary melanoma. This interaction is shown to be both specific and functional. Importantly, site-directed mutagenesis analysis reveals that the amino acid residues involved in the recognition of this novel ligand are different from those interacting with HLA-Cw4. These results may shed new light on the function of activating KIRs and their relevance in NK biology.

Type

Journal article

Journal

J Immunol

Publication Date

01/08/2004

Volume

173

Pages

1819 - 1825

Keywords

Amino Acid Sequence, Animals, Binding Sites, COS Cells, Cell Line, Tumor, Cercopithecus aethiops, Cytotoxicity, Immunologic, HLA-C Antigens, Histocompatibility Antigens Class I, Humans, Immunoglobulin Fc Fragments, Immunoglobulin G, Killer Cells, Natural, Ligands, Melanoma, Models, Molecular, Molecular Sequence Data, Mutagenesis, Site-Directed, Neoplasm Proteins, Protein Binding, Protein Conformation, Receptors, Immunologic, Receptors, KIR, Recombinant Fusion Proteins, Sequence Alignment, Sequence Homology, Amino Acid, Transfection